The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Zafrilla 2mg tablets

Gedeon Richter PlcPA1330/023/001

Main Information

Trade NameZafrilla 2mg tablets
Active SubstancesDienogest
Dosage FormTablet
Licence HolderGedeon Richter Plc
Licence NumberPA1330/023/001

Group Information

ATC CodeG03DB08 dienogest


License statusAuthorised
Licence Issued12/04/2019
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back